Determination of modulation of ligand properties of synthetic complex‐type biantennary N‐glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
We have investigated the consequences of introducing a bisecting GlcNAc moiety into biantennary N‐glycans. Computational analysis of glycan conformation with prolonged simulation periods in vacuo and in a solvent box revealed two main effects: backfolding of the α1–6 arm and stacking of the bisecting GlcNAc and the neighboring Man/GlcNAc residues of both antennae. Chemoenzymatic synthesis produced the bisecting biantennary decasaccharide N‐glycan and its α2–3(6)‐sialylated variants. They were conjugated to BSA to probe the ligand properties of N‐glycans with bisecting GlcNAc. To assess affinity alterations in glycan binding to receptors, testing was performed with purified lectins, cultured cells, tissue sections and animals. The panel of lectins, including an adhesion/growth‐regulatory galectin, revealed up to a sixfold difference in affinity constants for these neoglycoproteins relative to data on the unsubstituted glycans reported previously [André, S., Unverzagt, C., Kojima, S., Dong, X., Fink, C., Kayser, K. & Gabius, H.‐J. (1997) Bioconjugate Chem. 8, 845–855]. The enhanced affinity for galectin‐1 is in accord with the increased percentage of cell positivity in cytofluorimetric and histochemical analysis of carbohydrate‐dependent binding of labeled neoglycoproteins to cultured tumor cells and routinely processed lung cancer sections. Intravenous injection of iodinated neoglycoproteins carrying galactose‐terminated N‐glycans into mice revealed the highest uptake in liver and spleen for the bisecting compound compared with the unsubstituted or core‐fucosylated N‐glycans. Thus, this substitution modulates ligand properties in interactions with lectins, a key finding of this report. Synthetic glycan tailoring provides a versatile approach to the preparation of newly substituted glycans with favorable ligand properties for medical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yoshimura, M., Nishikawa, A., Ihara, Y., Taniguchi, S., & Taniguchi, N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8754 · Cited by 292 · cited 1×
“and decreased migration activity was observed for human U373 glioma cells bearing mutual overexpression of GnTIII relative to GnT-V (shift from biantennary N-glycans with bisecting GlcNAc to highly branched N-glycans), and GnT-III-overexpressing human K562 erythroleukemic cells rather effectively colonized the spleen…”
BackgroundEukaryotic glycosylation: whim of nature or multipurpose tool?
Reuter, G., & Gabius, H.-J. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050298 · Cited by 233
Self-citationThe Significance of Glycosylated Proteins
WINTERBURN, P. J., & PHELPS, C. F. (1972) · Nature · doi:10.1038/236147a0 · Cited by 213 · cited 1×
“Apart from having a bearing on the protein part’s folding or access to binding partners, the capacity of protein-bound glycan chains to impart a discrete recognitional role to the protein [24] deserves attention in this respect.”
BackgroundBinding and cross-linking properties of galectins
Fred Brewer, C. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00312-4 · Cited by 169
Cited by
Chemical Biology of the Sugar Code
Gabius, H., Siebert, H., André, S., Jiménez‐Barbero, J., & Rüdiger, H. (2004) · ChemBioChem · doi:10.1002/cbic.200300753 · Cited by 524
Self-citationLópez-Lucendo, M. F., Solís, D., André, S., Hirabayashi, J., Kasai, K.-I., Kaltner, H., Gabius, H.-J., & Romero, A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.078 · Cited by 295
Self-citationLiu, Y.-H., D'Ambrosio, M., Liao, T.-D., Peng, H., Rhaleb, N.-E., Sharma, U., André, S., Gabius, H.-J., & Carretero, O. A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00747.2008 · Cited by 269
Self-citationSolís, D., Bovin, N. V., Davis, A. P., Jiménez-Barbero, J., Romero, A., Roy, R., Smetana, K., & Gabius, H.-J. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.03.016 · Cited by 222
Self-citationGlycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies
Rocamora, F., Peralta, A. G., Shin, S., Sorrentino, J., Wu, M. Y. M., Toth, E. A., Fuerst, T. R., & Lewis, N. E. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108206 · Cited by 67
Metadata
- Authors
- André, S., Unverzagt, C., Kojima, S., Frank, M., Seifert, J., Fink, C., Kayser, K., von der Lieth, C., & Gabius, H.
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 2003-12-14
- Volume
- 271
- Issue
- 1
- Pages
- 118-134
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2151227852
- Cited by
- 118
- References
- 4
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determination of modulation of ligand properties of synthetic complex‐type biantennary N‐glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. https://app.cochat.ai/papers/10.1046/j.1432-1033.2003.03910.x
- The paper
- André, S., Unverzagt, C., Kojima, S., Frank, M., Seifert, J., Fink, C., Kayser, K., von der Lieth, C., & Gabius, H. (2004). Determination of modulation of ligand properties of synthetic complex‐type biantennary N‐glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. European Journal of Biochemistry. https://doi.org/10.1046/j.1432-1033.2003.03910.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.